nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—GNRHR—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0135	0.109	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0115	0.0923	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00755	0.0608	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.0071	0.0572	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00704	0.0567	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00536	0.0432	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00487	0.0392	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00427	0.0343	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00413	0.0332	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00386	0.0311	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00325	0.0262	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00294	0.0237	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00275	0.0222	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00263	0.0212	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00238	0.0192	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00224	0.018	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00224	0.018	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00201	0.0162	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00181	0.0146	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00171	0.0137	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00171	0.0137	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.0017	0.0137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00167	0.0134	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00163	0.0131	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00154	0.0124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00151	0.0121	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.0013	0.0105	CbGpPWpGaD
Nafarelin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00124	0.00141	CcSEcCtD
Nafarelin—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00123	0.00141	CcSEcCtD
Nafarelin—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00123	0.00141	CcSEcCtD
Nafarelin—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00122	0.0014	CcSEcCtD
Nafarelin—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00122	0.00139	CcSEcCtD
Nafarelin—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00121	0.00139	CcSEcCtD
Nafarelin—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Nafarelin—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Nafarelin—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Nafarelin—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Nafarelin—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00137	CcSEcCtD
Nafarelin—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.0012	0.00137	CcSEcCtD
Nafarelin—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.00137	CcSEcCtD
Nafarelin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0012	0.00137	CcSEcCtD
Nafarelin—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00118	0.00135	CcSEcCtD
Nafarelin—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00135	CcSEcCtD
Nafarelin—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00135	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00117	0.00942	CbGpPWpGaD
Nafarelin—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00133	CcSEcCtD
Nafarelin—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00133	CcSEcCtD
Nafarelin—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00133	CcSEcCtD
Nafarelin—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00116	0.00133	CcSEcCtD
Nafarelin—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00116	0.00133	CcSEcCtD
Nafarelin—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00132	CcSEcCtD
Nafarelin—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00115	0.00131	CcSEcCtD
Nafarelin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00131	CcSEcCtD
Nafarelin—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00131	CcSEcCtD
Nafarelin—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00114	0.00131	CcSEcCtD
Nafarelin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00114	0.0013	CcSEcCtD
Nafarelin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00113	0.00129	CcSEcCtD
Nafarelin—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00128	CcSEcCtD
Nafarelin—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00128	CcSEcCtD
Nafarelin—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00128	CcSEcCtD
Nafarelin—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00128	CcSEcCtD
Nafarelin—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00112	0.00128	CcSEcCtD
Nafarelin—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00127	CcSEcCtD
Nafarelin—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00127	CcSEcCtD
Nafarelin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00111	0.00127	CcSEcCtD
Nafarelin—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00127	CcSEcCtD
Nafarelin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Shock—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00126	CcSEcCtD
Nafarelin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.0011	0.00125	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00125	CcSEcCtD
Nafarelin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00109	0.00125	CcSEcCtD
Nafarelin—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00125	CcSEcCtD
Nafarelin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00109	0.00124	CcSEcCtD
Nafarelin—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00109	0.00124	CcSEcCtD
Nafarelin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00124	CcSEcCtD
Nafarelin—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00123	CcSEcCtD
Nafarelin—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00123	CcSEcCtD
Nafarelin—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00123	CcSEcCtD
Nafarelin—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00122	CcSEcCtD
Nafarelin—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00122	CcSEcCtD
Nafarelin—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00122	CcSEcCtD
Nafarelin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.0012	CcSEcCtD
Nafarelin—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.0012	CcSEcCtD
Nafarelin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.0012	CcSEcCtD
Nafarelin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.0012	CcSEcCtD
Nafarelin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00105	0.00119	CcSEcCtD
Nafarelin—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00119	CcSEcCtD
Nafarelin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00104	0.00119	CcSEcCtD
Nafarelin—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00118	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00103	0.00829	CbGpPWpGaD
Nafarelin—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00118	CcSEcCtD
Nafarelin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00117	CcSEcCtD
Nafarelin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00117	CcSEcCtD
Nafarelin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00103	0.00117	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00103	0.00826	CbGpPWpGaD
Nafarelin—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00117	CcSEcCtD
Nafarelin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00117	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00116	CcSEcCtD
Nafarelin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00101	0.00116	CcSEcCtD
Nafarelin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00101	0.00116	CcSEcCtD
Nafarelin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00116	CcSEcCtD
Nafarelin—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00101	0.00115	CcSEcCtD
Nafarelin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00115	CcSEcCtD
Nafarelin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00115	CcSEcCtD
Nafarelin—Rash—Didanosine—acquired immunodeficiency syndrome	0.001	0.00115	CcSEcCtD
Nafarelin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.001	0.00115	CcSEcCtD
Nafarelin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.001	0.00115	CcSEcCtD
Nafarelin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000998	0.00114	CcSEcCtD
Nafarelin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000997	0.00114	CcSEcCtD
Nafarelin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000995	0.00114	CcSEcCtD
Nafarelin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000994	0.00114	CcSEcCtD
Nafarelin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000992	0.00113	CcSEcCtD
Nafarelin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000992	0.00113	CcSEcCtD
Nafarelin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00099	0.00113	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000985	0.00793	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000985	0.00793	CbGpPWpGaD
Nafarelin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000982	0.00112	CcSEcCtD
Nafarelin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00098	0.00112	CcSEcCtD
Nafarelin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000979	0.00112	CcSEcCtD
Nafarelin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000978	0.00112	CcSEcCtD
Nafarelin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000977	0.00112	CcSEcCtD
Nafarelin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000975	0.00111	CcSEcCtD
Nafarelin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000975	0.00111	CcSEcCtD
Nafarelin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000975	0.00111	CcSEcCtD
Nafarelin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000972	0.00111	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000964	0.00776	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000964	0.00776	CbGpPWpGaD
Nafarelin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000964	0.0011	CcSEcCtD
Nafarelin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000963	0.0011	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000962	0.0011	CcSEcCtD
Nafarelin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000956	0.00109	CcSEcCtD
Nafarelin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000955	0.00109	CcSEcCtD
Nafarelin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000955	0.00109	CcSEcCtD
Nafarelin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000955	0.00109	CcSEcCtD
Nafarelin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000949	0.00108	CcSEcCtD
Nafarelin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000949	0.00108	CcSEcCtD
Nafarelin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000946	0.00108	CcSEcCtD
Nafarelin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000946	0.00108	CcSEcCtD
Nafarelin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000945	0.00108	CcSEcCtD
Nafarelin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000942	0.00108	CcSEcCtD
Nafarelin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000938	0.00107	CcSEcCtD
Nafarelin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000938	0.00107	CcSEcCtD
Nafarelin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000938	0.00107	CcSEcCtD
Nafarelin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000935	0.00107	CcSEcCtD
Nafarelin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000932	0.00106	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000931	0.0075	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000921	0.00105	CcSEcCtD
Nafarelin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00092	0.00105	CcSEcCtD
Nafarelin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000918	0.00105	CcSEcCtD
Nafarelin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000917	0.00105	CcSEcCtD
Nafarelin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000915	0.00104	CcSEcCtD
Nafarelin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000914	0.00104	CcSEcCtD
Nafarelin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000911	0.00104	CcSEcCtD
Nafarelin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000911	0.00104	CcSEcCtD
Nafarelin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000908	0.00104	CcSEcCtD
Nafarelin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000904	0.00103	CcSEcCtD
Nafarelin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000903	0.00103	CcSEcCtD
Nafarelin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000903	0.00103	CcSEcCtD
Nafarelin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000902	0.00103	CcSEcCtD
Nafarelin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000901	0.00103	CcSEcCtD
Nafarelin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000901	0.00103	CcSEcCtD
Nafarelin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.0009	0.00103	CcSEcCtD
Nafarelin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000897	0.00102	CcSEcCtD
Nafarelin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000895	0.00102	CcSEcCtD
Nafarelin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000895	0.00102	CcSEcCtD
Nafarelin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000895	0.00102	CcSEcCtD
Nafarelin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000891	0.00102	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00089	0.00717	CbGpPWpGaD
Nafarelin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000888	0.00101	CcSEcCtD
Nafarelin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000885	0.00101	CcSEcCtD
Nafarelin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000882	0.00101	CcSEcCtD
Nafarelin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000879	0.001	CcSEcCtD
Nafarelin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000879	0.001	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000876	0.00705	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000876	0.00705	CbGpPWpGaD
Nafarelin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000875	0.000999	CcSEcCtD
Nafarelin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000874	0.000998	CcSEcCtD
Nafarelin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000872	0.000996	CcSEcCtD
Nafarelin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000871	0.000995	CcSEcCtD
Nafarelin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00087	0.000993	CcSEcCtD
Nafarelin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000869	0.000992	CcSEcCtD
Nafarelin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000866	0.000989	CcSEcCtD
Nafarelin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000866	0.000989	CcSEcCtD
Nafarelin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000864	0.000987	CcSEcCtD
Nafarelin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000863	0.000985	CcSEcCtD
Nafarelin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000859	0.000981	CcSEcCtD
Nafarelin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000858	0.00098	CcSEcCtD
Nafarelin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000858	0.00098	CcSEcCtD
Nafarelin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000857	0.000979	CcSEcCtD
Nafarelin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000854	0.000975	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000852	0.000972	CcSEcCtD
Nafarelin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000851	0.000972	CcSEcCtD
Nafarelin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000851	0.000971	CcSEcCtD
Nafarelin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000845	0.000965	CcSEcCtD
Nafarelin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000844	0.000964	CcSEcCtD
Nafarelin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000839	0.000958	CcSEcCtD
Nafarelin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000839	0.000958	CcSEcCtD
Nafarelin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000833	0.000951	CcSEcCtD
Nafarelin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00083	0.000947	CcSEcCtD
Nafarelin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000824	0.000941	CcSEcCtD
Nafarelin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000823	0.000939	CcSEcCtD
Nafarelin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000822	0.000938	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00082	0.000936	CcSEcCtD
Nafarelin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000818	0.000934	CcSEcCtD
Nafarelin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000814	0.000929	CcSEcCtD
Nafarelin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000812	0.000928	CcSEcCtD
Nafarelin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000809	0.000924	CcSEcCtD
Nafarelin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000808	0.000922	CcSEcCtD
Nafarelin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000803	0.000917	CcSEcCtD
Nafarelin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000802	0.000916	CcSEcCtD
Nafarelin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000802	0.000916	CcSEcCtD
Nafarelin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000799	0.000913	CcSEcCtD
Nafarelin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000795	0.000908	CcSEcCtD
Nafarelin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000791	0.000903	CcSEcCtD
Nafarelin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000782	0.000893	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000782	0.000893	CcSEcCtD
Nafarelin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000776	0.000886	CcSEcCtD
Nafarelin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000771	0.00088	CcSEcCtD
Nafarelin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000769	0.000878	CcSEcCtD
Nafarelin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000765	0.000874	CcSEcCtD
Nafarelin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000765	0.000873	CcSEcCtD
Nafarelin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000764	0.000873	CcSEcCtD
Nafarelin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000758	0.000865	CcSEcCtD
Nafarelin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000758	0.000865	CcSEcCtD
Nafarelin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000757	0.000865	CcSEcCtD
Nafarelin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000753	0.00086	CcSEcCtD
Nafarelin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000747	0.000853	CcSEcCtD
Nafarelin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000746	0.000852	CcSEcCtD
Nafarelin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000742	0.000848	CcSEcCtD
Nafarelin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000739	0.000844	CcSEcCtD
Nafarelin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000734	0.000838	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000734	0.00591	CbGpPWpGaD
Nafarelin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000725	0.000828	CcSEcCtD
Nafarelin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000723	0.000825	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000723	0.00582	CbGpPWpGaD
Nafarelin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000715	0.000816	CcSEcCtD
Nafarelin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000715	0.000816	CcSEcCtD
Nafarelin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000714	0.000815	CcSEcCtD
Nafarelin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000711	0.000812	CcSEcCtD
Nafarelin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000705	0.000805	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000704	0.00567	CbGpPWpGaD
Nafarelin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000704	0.000804	CcSEcCtD
Nafarelin—Headache—Indinavir—acquired immunodeficiency syndrome	0.0007	0.0008	CcSEcCtD
Nafarelin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000699	0.000798	CcSEcCtD
Nafarelin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000692	0.00079	CcSEcCtD
Nafarelin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000682	0.000778	CcSEcCtD
Nafarelin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000672	0.000767	CcSEcCtD
Nafarelin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000671	0.000766	CcSEcCtD
Nafarelin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000668	0.000763	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000666	0.00536	CbGpPWpGaD
Nafarelin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000666	0.00076	CcSEcCtD
Nafarelin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000665	0.00076	CcSEcCtD
Nafarelin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000664	0.000758	CcSEcCtD
Nafarelin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000662	0.000756	CcSEcCtD
Nafarelin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000661	0.000755	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000661	0.00532	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000656	0.00528	CbGpPWpGaD
Nafarelin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000645	0.000737	CcSEcCtD
Nafarelin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000643	0.000734	CcSEcCtD
Nafarelin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000639	0.00073	CcSEcCtD
Nafarelin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000637	0.000728	CcSEcCtD
Nafarelin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000637	0.000727	CcSEcCtD
Nafarelin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000636	0.000727	CcSEcCtD
Nafarelin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000633	0.000723	CcSEcCtD
Nafarelin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000627	0.000716	CcSEcCtD
Nafarelin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000618	0.000706	CcSEcCtD
Nafarelin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000616	0.000703	CcSEcCtD
Nafarelin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000615	0.000703	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000608	0.0049	CbGpPWpGaD
Nafarelin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000607	0.000693	CcSEcCtD
Nafarelin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.0006	0.000685	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.0006	0.00483	CbGpPWpGaD
Nafarelin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000595	0.000679	CcSEcCtD
Nafarelin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000594	0.000679	CcSEcCtD
Nafarelin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000589	0.000673	CcSEcCtD
Nafarelin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000589	0.000672	CcSEcCtD
Nafarelin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000587	0.00067	CcSEcCtD
Nafarelin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000586	0.000669	CcSEcCtD
Nafarelin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000572	0.000653	CcSEcCtD
Nafarelin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000567	0.000648	CcSEcCtD
Nafarelin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000567	0.000648	CcSEcCtD
Nafarelin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000567	0.000647	CcSEcCtD
Nafarelin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000564	0.000643	CcSEcCtD
Nafarelin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000555	0.000634	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00055	0.00443	CbGpPWpGaD
Nafarelin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000546	0.000623	CcSEcCtD
Nafarelin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000541	0.000618	CcSEcCtD
Nafarelin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000541	0.000617	CcSEcCtD
Nafarelin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000538	0.000614	CcSEcCtD
Nafarelin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000534	0.00061	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000517	0.00417	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000517	0.00417	CbGpPWpGaD
Nafarelin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00051	0.000582	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000393	0.00317	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000388	0.00312	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000382	0.00307	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000354	0.00285	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000347	0.00279	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000205	0.00165	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000204	0.00164	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.00012	0.00097	CbGpPWpGaD
